Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04676399Phase 1Active, not recruiting
Phase 1, randomised trial in chronic pain comparing Hydrochlorothiazide Pill (12.5 mg twice a day) with Placebo (2 arms). Primary endpoints: Change in Blood Pressure Measurement at 2 weeks, Change in PainDETECT Questionnaire at 2 weeks and 4 more. Started Feb 2022; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04676399.